Evidence map›Paper›PMID 20018617›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2010

Cutting edge: Sympathetic nervous system increases proinflammatory cytokines and exacerbates influenza A virus pathogenesis.

Kristie M Grebe, Kazuyo Takeda, Heather D Hickman, Adam L Bailey, Adam M Bailey, Alan C Embry, Jack R Bennink, Jonathan W Yewdell

Erratum issued Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT05638620 (Evaluating the Effectiveness of Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Post-Acute Sequelae of SARS-CoV-2), which is not on this map. Cited by 79 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05638620 phase1completednot on this mapstarted 2023, after this paper: background citation

Evaluating the Effectiveness of Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Post-Acute Sequelae of SARS-CoV-2 (PASC)

TypeinterventionalSponsorJonathann Kuo, MDRan2023 to 2023Enrolled20ConditionsPost Acute COVID-19 Syndrome, Long COVID, Long Covid19, COVID-19 RecurrentArmsstellate ganglion block with 0.5% bupivacaine
3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 1 synthesis or guideline pooled it, 127 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Carbidopa: beyond Parkinson's disease.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2025
    Review
  10. Article
  11. Review
  12. T cells at the interface of neuroimmune communication.The Journal of allergy and clinical immunology · 2024
    Review
  13. Neuroimmune recognition and regulation in the respiratory system.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Effects of atrial fibrillation on outcomes of influenza hospitalization.International journal of cardiology. Heart & vasculature · 2022
    Article
  19. Article
  20. Review

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
    Bailey, Adam M [corrected to Bailey, Adam L]
5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Kristie M GrebeLaboratories of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Kazuyo Takeda
Heather D Hickman
Adam L Bailey
Adam M Bailey
Alan C Embry
Jack R Bennink
Jonathan W Yewdell
National Institute of Allergy and Infectious Diseases · US

Funding

Physiology of Viral ImmunityZIAAI001054 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BENNINK, JACK R · 2009 to 2011
$1.5M
Physiology of Viral ImmunityZ01AI001054 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BENNINK, JACK R · 2008 to 2008
$533k
Intramural NIH HHS Z01 AI001054
6 · The paper itself

Abstract

Although the sympathetic nervous system innervates the lung, little is known about its participation in host immunity to pulmonary pathogens. In this study, we show that peripheral sympathectomy reduces mouse morbidity and mortality from influenza A virus-induced pneumonia due to reduced inflammatory influx of monocytes, neutrophils, and NK cells. Mortality was also delayed by treating mice with an alpha-adrenergic antagonist. Sympathectomy diminished the immediate innate cytokine responses, particularly IL-1, which was profoundly reduced. These findings demonstrate an unexpected role for the sympathetic nervous system in innate antiviral immunity and in exacerbating the pathology of a virus of great significance to human and animal health.

Indexed as

AnimalsCell MovementCytokinesImmunity, InnateInflammationInfluenza A virusInterleukin-1MiceOrthomyxoviridae InfectionsPneumoniaSurvival RateSympathectomySympathetic Nervous SystemCytokinesInterleukin-1

Identifiers

PMID20018617
PMCPMC2941093
OpenAlexW2158175641

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.